1. Home
  2. Publications & Resources
  3. Publications
  4. National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn
Print this page Reduce font size Increase font size

National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn

Summary

These nationally agreed clinical guidelines are intended to support a range of health care workers who care for women with drug and alcohol use issues, and their infants and families. They have been developed through a process based on evidence reviews and expert consensus. The drugs covered include: opioids, alcohol, tobacco, cannabis, amphetamines, cocaine, benzodiazepines, inhalants.

Other topics covered are: breastfeeding, vertical transmission of blood-borne viruses, psychosocial aspects, obstetric implications, pain management in labour and early childhood development. Aboriginal and Torres Strait Islander issues are also addressed.

File link: National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn
File size: 1155Kb
Type: Guideline
Date of Publication: 01 March 2006
Author Branch: Drug & Alcohol Office
SHPN: 060083
ISBN: 0 7347 3947 8

National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn

Related links


Print this page Reduce font size Increase font size

This web page and associated publication are managed and authorised by Drug & Alcohol Office of Mental Health & Drug & Alcohol Office of the NSW Department of Health. Last updated: 7 October, 2009